查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1773766

多重免疫测量市场：全球产业分析、市场规模、份额、成长、趋势和未来预测（2025-2032 年）

Multiplex Detection Immunoassay Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
出版日期: | 出版商: Persistence Market Research | 英文 199 Pages | 商品交期: 2-5个工作天内

价格
简介目录

Persistence Market Research 最近发布了一份关于全球多重检测免疫测量市场的全面分析报告。该报告对关键市场动态进行了全面评估，包括市场驱动因素、趋势、机会和挑战，并深入分析了市场结构。报告提供了独家数据和统计数据，概述了全球多重检测免疫测量市场的预测成长轨迹（2025-2032 年）。

关键见解

  • 多重免疫测量市场规模（2025年）：32亿美元
  • 市场规模预测（以金额为准，2032年）：44亿美元
  • 全球市场成长率（2025-2032年复合年增长率）：4.4%

多重检测免疫测量市场－分析范围

多重检测免疫测量市场是指能够在单次检测中同时检测和定量多种生物标记的先进诊断技术。这些检测方法在疾病诊断、药物研发和生物医学研究中至关重要，具有高通量、低试剂成本和快速获得结果等优势。慢性病和感染疾病的日益流行，加上对早期诊断和精准医疗的重视，正在推动临床和研究领域对多重检测技术的需求。

市场成长动力：

由于癌症、自体免疫疾病和感染疾病等需要高阶诊断的慢性疾病的增多，全球多重检测免疫测量市场正经历强劲成长。对经济高效、高通量筛检工具的需求，推动了多重检测在临床和研究环境中的应用。此外，个人化医疗的转变以及对高效药物开发流程的需求，正在加速多重检测技术的应用。研发资金的增加以及製药公司和诊断公司之间日益加强的合作，也大大促进了市场的扩张。

市场限制：

儘管多重检测免疫测量市场具有显着优势，但也面临许多限制因素。高昂的初始投资成本和检测方法开发的复杂性可能会阻碍其应用，尤其是在小型实验室和新兴经济体中。交叉反应和跨平台标准化程度有限等技术挑战可能会影响检测的准确性和可重复性。此外，多重检测的核准和商业化相关的监管障碍增加了新参与企业的市场准入难度，从而抑制了整体成长。

市场机会：

多重检测免疫测量市场蕴含着庞大的商机，尤其是在检测设计、微流体和自动化技术不断进步的背景下。向医疗基础设施快速发展的南美、拉丁美洲和非洲等新兴市场扩张，代表着一条充满希望的成长途径。多重检测平台在药物开发和生物标记检验的应用日益增多，为诊断和生物技术公司带来了丰厚的前景。策略伙伴关係、持续创新以及将人工智慧和数据分析融入检测解读，预计将在未来几年创造竞争优势并开闢新的应用领域。

本报告回答的关键问题

  • 推动多重检测免疫测量市场成长的关键因素有哪些？
  • 预测期内哪些技术和应用领域可望占据领先地位？
  • 个人化医疗等医疗保健趋势如何影响市场需求？
  • 全球多重检测免疫测量市场的主要企业有哪些？他们采用了哪些策略？
  • 各地区的成长预测如何？

目录

第一章执行摘要

第二章 市场概述

  • 市场范围和定义
  • 市场动态
    • 驱动程式
    • 限制因素
    • 机会
    • 主要趋势
  • 宏观经济因素
    • 全球产业展望
    • 全球GDP成长前景
  • COVID-19影响分析
  • 预测因子－相关性和影响力

第三章 加值分析

  • 产品采用分析
  • 监管状况
  • 价值链分析
  • 重大交易及合併
  • PESTLE分析
  • 波特五力分析

第四章 定价分析（2025年）

  • 主要亮点
  • 影响产品价格的关键因素
  • 按产品进行价格分析
  • 区域价格和产品偏好

5. 全球多重免疫测量市场展望

  • 主要亮点
    • 市场规模预测（以数量为基础）
    • 市场规模及年成长率（以金额为准）
    • 绝对的商机
  • 市场规模分析与预测（以金额为准）
    • 历史市场规模分析（以金额为准，2019-2024）
    • 当前市场规模分析与预测（以金额为准，2025-2032）
  • 全球多重检测免疫测量市场（按产品）展望
    • 引言/主要发现
    • 按产品分類的历史市场规模分析（价值与数量基础，2019-2024 年）
    • 按产品分類的市场规模分析和预测（价值和数量基础，2025-2032 年）
      • 装置
      • 套件和试剂
      • 软体与服务
    • 市场吸引力分析：按产品
  • 全球多重免疫测量市场展望（依方法）
    • 引言/主要发现
    • 依方法论进行的历史市场规模分析（价值和数量，2019-2024）
    • 依方法论进行的市场规模分析和预测（价值和数量基础，2025 年至 2032 年）
      • 核酸多重检测
      • 蛋白质多重检测
      • 基于细胞的多重分析
    • 市场吸引力分析：依方法
  • 全球多重检测免疫测量市场技术展望
    • 引言/主要发现
    • 按技术分類的历史市场规模分析（价值和数量基础，2019-2024 年）
    • 按技术分類的市场规模分析和预测（价值和数量，2025-2032）
      • 流式细胞技术
      • 以微珠为基础的多重检测
      • 照明
      • 多重即时PCR
      • 其他的
    • 市场吸引力分析：按技术
  • 全球多重检测免疫测量市场应用展望
    • 引言/主要发现
    • 按应用分類的历史市场规模分析（价值和数量基础，2019-2024 年）
    • 按应用分類的市场规模分析和预测（价值和数量基础，2025 年至 2032 年）
      • 疾病诊断
      • 研究与开发
      • 药物研发
      • 其他的
    • 市场吸引力分析：按应用
  • 全球多重检测免疫测量市场前景（按最终用户）
    • 引言/主要发现
    • 按最终用户分類的历史市场规模分析（价值和数量基础，2019-2024 年）
    • 最终用户的市场规模分析和预测（价值和数量基础，2025-2032）
      • 製药和生物技术公司
      • CRO（委外研发机构）
      • 学术研究所
      • 诊断与参考实验室
      • 其他的
    • 最终用户的市场吸引力分析

6. 全球多重检测免疫测量市场（按地区）展望

  • 主要亮点
  • 按地区分類的历史市场规模分析（价值和数量基础，2019-2024 年）
  • 按地区分類的市场规模分析和预测（价值和数量基础，2025 年至 2032 年）
    • 北美洲
    • 欧洲
    • 东亚
    • 南亚和大洋洲
    • 拉丁美洲
    • 中东和非洲
  • 按地区分析市场吸引力

7. 北美多重免疫测量市场展望

8. 欧洲多重免疫测量市场展望

9. 东亚多重免疫测量市场展望

10.南亚和大洋洲多重检测免疫测量市场展望

11. 拉丁美洲多重免疫测量市场展望

12. 中东和非洲多重免疫测量市场展望

第十三章竞争格局

  • 市场占有率分析（2025年）
  • 市场结构
    • 竞争强度图：按市场
    • 竞争仪錶板
  • 公司简介（详情：概述、财务状况、策略、最新发展）
    • Meridian Bioscience
    • Thermo Fisher Scientific Inc.
    • Bio-Rad Laboratories, Inc.
    • QIAGEN
    • Bio-Techne
    • DiaSorin SpA
    • BIOMERIEUX
    • Quanterix
    • Randox Laboratories Ltd.
    • Merck KGaA
    • Revvity
    • F. Hoffmann-La Roche Ltd
    • Sartorius AG
    • Seegene Inc.
    • BioGenex
    • Miltenyi Biotec
    • SouthernBiotech
    • Healgen
    • Sepmag
    • Curiox Biosystems
    • MESO SCALE DIAGNOSTICS, LLC
    • Wuxi NEST Biotechnology Co.,Ltd

第十四章 附录

  • 分析方法
  • 分析假设
  • 首字母缩写和简称
简介目录
Product Code: PMRREP11542

Persistence Market Research has recently released a comprehensive report on the global Multiplex Detection Immunoassay Market, offering an in-depth evaluation of market dynamics, including key growth drivers, restraints, opportunities, and emerging trends. This report serves as a valuable resource for industry stakeholders, providing insights into market potential, competitive landscape, and strategic recommendations for future growth.

Key Insights:

  • Multiplex Detection Immunoassay Market Size (2025E): US$ 3.2 Bn
  • Projected Market Value (2032F): US$ 4.4 Bn
  • Global Market Growth Rate (CAGR 2025 to 2032): 4.4%

Multiplex Detection Immunoassay Market - Report Scope:

The multiplex detection immunoassay market refers to advanced diagnostic technologies that allow simultaneous detection and quantification of multiple biomarkers in a single assay. These assays are crucial in disease diagnostics, drug discovery, and biomedical research, offering high throughput, reduced reagent costs, and faster results. Growing prevalence of chronic and infectious diseases, combined with increased emphasis on early diagnosis and precision medicine, is enhancing the demand for multiplex technologies across clinical and research settings.

Market Growth Drivers:

The global multiplex detection immunoassay market is experiencing robust growth driven by rising incidences of chronic illnesses such as cancer, autoimmune diseases, and infectious conditions that require advanced diagnostics. The demand for cost-effective and high-throughput screening tools has propelled the adoption of multiplex assays in both clinical and research environments. Additionally, the shift towards personalized medicine and the need for efficient drug development processes are accelerating the use of multiplex technologies. Increased funding for R&D and growing collaborations between pharmaceutical companies and diagnostics firms are also contributing significantly to market expansion.

Market Restraints:

Despite its significant advantages, the multiplex detection immunoassay market faces several limitations. High initial investment costs and the complexity of assay development may hinder adoption, particularly among smaller laboratories and emerging economies. Technical challenges such as cross-reactivity and limited standardization across platforms can affect assay accuracy and reproducibility. Furthermore, regulatory hurdles associated with multiplex assay approval and commercialization add to the complexity of market entry for new players, restraining overall growth.

Market Opportunities:

The multiplex detection immunoassay market holds substantial opportunities, especially with technological advancements in assay design, microfluidics, and automation. Expansion into emerging markets such as South Asia, Latin America, and Africa, where healthcare infrastructure is rapidly evolving, provides a promising growth avenue. The increasing use of multiplex platforms in drug development and biomarker validation offers lucrative prospects for diagnostic and biotech firms. Strategic partnerships, continuous innovation, and the integration of AI and data analytics into assay interpretation are expected to create competitive advantages and unlock new application areas in the coming years.

Key Questions Answered in the Report:

  • What are the main factors driving growth in the multiplex detection immunoassay market?
  • Which technology and application segments are expected to lead during the forecast period?
  • How are healthcare trends such as personalized medicine influencing market demand?
  • Who are the key players in the global multiplex immunoassay space and what strategies are they adopting?
  • What is the projected growth across different geographic regions?

Competitive Intelligence and Business Strategy:

Leading companies in the multiplex detection immunoassay market, such as Thermo Fisher Scientific Inc., Bio-Rad Laboratories, QIAGEN, and Merck KGaA, are focusing on R&D investments and product innovation to enhance assay sensitivity and flexibility. Strategic collaborations with CROs and pharmaceutical companies are enabling better integration of multiplex assays in clinical trials and drug discovery pipelines. Furthermore, companies are expanding their global footprint through acquisitions, distribution partnerships, and entry into high-growth emerging markets. Emphasis on automation, miniaturization, and digital data analysis is further enhancing their competitive positioning.

Companies Covered in This Report:

  • Meridian Bioscience
  • Thermo Fisher Scientific Inc.
  • Bio-Rad Laboratories, Inc.
  • QIAGEN
  • Bio-Techne
  • DiaSorin S.p.A.
  • BIOMERIEUX
  • Quanterix
  • Randox Laboratories Ltd.
  • Merck KGaA
  • Revvity
  • F. Hoffmann-La Roche Ltd
  • Sartorius AG
  • Seegene Inc.
  • BioGenex
  • Miltenyi Biotec

Market Segmentation:

By Product:

  • Instruments
  • Kits & Reagents
  • Software & Services

By Technique:

  • Nucleic Acid Multiplex Assays
  • Protein Multiplex Assays
  • Cell-Based Multiplex Assays

By Technology:

  • Flow Cytometry
  • Multiplex Bead-Based Assay
  • Luminescence
  • Multiplex Real-Time PCR
  • Others

By Application:

  • Disease Diagnostics
  • Research & Development
  • Drug Discovery & Development
  • Others

By End User:

  • Pharmaceutical & Biotech Companies
  • Clinical Research Organizations (CROs)
  • Academic Research Institutes
  • Diagnostic and Reference Laboratories
  • Others

By Region:

  • North America
  • Europe
  • East Asia
  • South Asia and Oceania
  • Latin America
  • Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Multiplex Detection Immunoassay Market Snapshot, 2025 and 2032
  • 1.2. Market Opportunity Assessment, 2025-2032, US$ Mn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Key Trends
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global Sectorial Outlook
    • 2.3.2. Global GDP Growth Outlook
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Product Adoption Analysis
  • 3.2. Regulatory Landscape
  • 3.3. Value Chain Analysis
  • 3.4. Key Deals and Mergers
  • 3.5. PESTLE Analysis
  • 3.6. Porter's Five Force Analysis

4. Price Analysis, 2025A

  • 4.1. Key Highlights
  • 4.2. Key Factors Impacting Product Prices
  • 4.3. Pricing Analysis, By Product
  • 4.4. Regional Prices and Product Preferences

5. Global Multiplex Detection Immunoassay Market Outlook

  • 5.1. Key Highlights
    • 5.1.1. Market Volume (Units) Projections
    • 5.1.2. Market Size (US$ Mn) and Y-o-Y Growth
    • 5.1.3. Absolute $ Opportunity
  • 5.2. Market Size (US$ Mn) Analysis and Forecast
    • 5.2.1. Historical Market Size (US$ Mn) Analysis, 2019-2024
    • 5.2.2. Market Size (US$ Mn) Analysis and Forecast, 2025-2032
  • 5.3. Global Multiplex Detection Immunoassay Market Outlook: Product
    • 5.3.1. Introduction / Key Findings
    • 5.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Product, 2019-2024
    • 5.3.3. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
      • 5.3.3.1. Instruments
      • 5.3.3.2. Kits & Reagents
      • 5.3.3.3. Software & Services
    • 5.3.4. Market Attractiveness Analysis: Product
  • 5.4. Global Multiplex Detection Immunoassay Market Outlook: Technique
    • 5.4.1. Introduction / Key Findings
    • 5.4.2. Historical Market Size (US$ Mn) Analysis, By Technique, 2019-2024
    • 5.4.3. Market Size (US$ Mn) Analysis and Forecast, By Technique, 2025-2032
      • 5.4.3.1. Nucleic Acid Multiplex Assays
      • 5.4.3.2. Protein Multiplex Assays
      • 5.4.3.3. Cell-Based Multiplex Assays
    • 5.4.4. Market Attractiveness Analysis: Technique
  • 5.5. Global Multiplex Detection Immunoassay Market Outlook: Technology
    • 5.5.1. Introduction / Key Findings
    • 5.5.2. Historical Market Size (US$ Mn) Analysis, By Technology, 2019-2024
    • 5.5.3. Market Size (US$ Mn) Analysis and Forecast, By Technology, 2025-2032
      • 5.5.3.1. Flow Cytometry
      • 5.5.3.2. Multiplex Bead-Based Assay
      • 5.5.3.3. Luminescence
      • 5.5.3.4. Multiplex Real-Time PCR
      • 5.5.3.5. Others
    • 5.5.4. Market Attractiveness Analysis: Technology
  • 5.6. Global Multiplex Detection Immunoassay Market Outlook: Application
    • 5.6.1. Introduction / Key Findings
    • 5.6.2. Historical Market Size (US$ Mn) Analysis, By Application, 2019-2024
    • 5.6.3. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
      • 5.6.3.1. Disease Diagnostics
      • 5.6.3.2. Research & Development
      • 5.6.3.3. Drug Discovery & Development
      • 5.6.3.4. Others
    • 5.6.4. Market Attractiveness Analysis: Application
  • 5.7. Global Multiplex Detection Immunoassay Market Outlook: End User
    • 5.7.1. Introduction / Key Findings
    • 5.7.2. Historical Market Size (US$ Mn) Analysis, By End User, 2019-2024
    • 5.7.3. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
      • 5.7.3.1. Pharmaceutical & Biotech Companies
      • 5.7.3.2. Clinical Research Organizations (CROs)
      • 5.7.3.3. Academic Research Institutes
      • 5.7.3.4. Diagnostic and Reference Laboratories
      • 5.7.3.5. Others
    • 5.7.4. Market Attractiveness Analysis: End User

6. Global Multiplex Detection Immunoassay Market Outlook: Region

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Mn) Analysis, By Region, 2019-2024
  • 6.3. Market Size (US$ Mn) Analysis and Forecast, By Region, 2025-2032
    • 6.3.1. North America
    • 6.3.2. Europe
    • 6.3.3. East Asia
    • 6.3.4. South Asia and Oceania
    • 6.3.5. Latin America
    • 6.3.6. Middle East & Africa
  • 6.4. Market Attractiveness Analysis: Region

7. North America Multiplex Detection Immunoassay Market Outlook

  • 7.1. Key Highlights
  • 7.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 7.2.1. By Country
    • 7.2.2. By Product
    • 7.2.3. By Technique
    • 7.2.4. By Technology
    • 7.2.5. By Application
    • 7.2.6. By End User
  • 7.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 7.3.1. U.S.
    • 7.3.2. Canada
  • 7.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 7.4.1. Instruments
    • 7.4.2. Kits & Reagents
    • 7.4.3. Software & Services
  • 7.5. Market Size (US$ Mn) Analysis and Forecast, By Technique, 2025-2032
    • 7.5.1. Nucleic Acid Multiplex Assays
    • 7.5.2. Protein Multiplex Assays
    • 7.5.3. Cell-Based Multiplex Assays
  • 7.6. Market Size (US$ Mn) Analysis and Forecast, By Technology, 2025-2032
    • 7.6.1. Flow Cytometry
    • 7.6.2. Multiplex Bead-Based Assay
    • 7.6.3. Luminescence
    • 7.6.4. Multiplex Real-Time PCR
    • 7.6.5. Others
  • 7.7. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 7.7.1. Disease Diagnostics
    • 7.7.2. Research & Development
    • 7.7.3. Drug Discovery & Development
    • 7.7.4. Others
  • 7.8. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 7.8.1. Pharmaceutical & Biotech Companies
    • 7.8.2. Clinical Research Organizations (CROs)
    • 7.8.3. Academic Research Institutes
    • 7.8.4. Diagnostic and Reference Laboratories
    • 7.8.5. Others
  • 7.9. Market Attractiveness Analysis

8. Europe Multiplex Detection Immunoassay Market Outlook

  • 8.1. Key Highlights
  • 8.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 8.2.1. By Country
    • 8.2.2. By Product
    • 8.2.3. By Technique
    • 8.2.4. By Technology
    • 8.2.5. By Application
    • 8.2.6. By End User
  • 8.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 8.3.1. Germany
    • 8.3.2. France
    • 8.3.3. U.K.
    • 8.3.4. Italy
    • 8.3.5. Spain
    • 8.3.6. Russia
    • 8.3.7. Turkey
    • 8.3.8. Rest of Europe
  • 8.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 8.4.1. Instruments
    • 8.4.2. Kits & Reagents
    • 8.4.3. Software & Services
  • 8.5. Market Size (US$ Mn) Analysis and Forecast, By Technique, 2025-2032
    • 8.5.1. Nucleic Acid Multiplex Assays
    • 8.5.2. Protein Multiplex Assays
    • 8.5.3. Cell-Based Multiplex Assays
  • 8.6. Market Size (US$ Mn) Analysis and Forecast, By Technology, 2025-2032
    • 8.6.1. Flow Cytometry
    • 8.6.2. Multiplex Bead-Based Assay
    • 8.6.3. Luminescence
    • 8.6.4. Multiplex Real-Time PCR
    • 8.6.5. Others
  • 8.7. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 8.7.1. Disease Diagnostics
    • 8.7.2. Research & Development
    • 8.7.3. Drug Discovery & Development
    • 8.7.4. Others
  • 8.8. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 8.8.1. Pharmaceutical & Biotech Companies
    • 8.8.2. Clinical Research Organizations (CROs)
    • 8.8.3. Academic Research Institutes
    • 8.8.4. Diagnostic and Reference Laboratories
    • 8.8.5. Others
  • 8.9. Market Attractiveness Analysis

9. East Asia Multiplex Detection Immunoassay Market Outlook

  • 9.1. Key Highlights
  • 9.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 9.2.1. By Country
    • 9.2.2. By Product
    • 9.2.3. By Technique
    • 9.2.4. By Technology
    • 9.2.5. By Application
    • 9.2.6. By End User
  • 9.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 9.3.1. China
    • 9.3.2. Japan
    • 9.3.3. South Korea
  • 9.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 9.4.1. Instruments
    • 9.4.2. Kits & Reagents
    • 9.4.3. Software & Services
  • 9.5. Market Size (US$ Mn) Analysis and Forecast, By Technique, 2025-2032
    • 9.5.1. Nucleic Acid Multiplex Assays
    • 9.5.2. Protein Multiplex Assays
    • 9.5.3. Cell-Based Multiplex Assays
  • 9.6. Market Size (US$ Mn) Analysis and Forecast, By Technology, 2025-2032
    • 9.6.1. Flow Cytometry
    • 9.6.2. Multiplex Bead-Based Assay
    • 9.6.3. Luminescence
    • 9.6.4. Multiplex Real-Time PCR
    • 9.6.5. Others
  • 9.7. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 9.7.1. Disease Diagnostics
    • 9.7.2. Research & Development
    • 9.7.3. Drug Discovery & Development
    • 9.7.4. Others
  • 9.8. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 9.8.1. Pharmaceutical & Biotech Companies
    • 9.8.2. Clinical Research Organizations (CROs)
    • 9.8.3. Academic Research Institutes
    • 9.8.4. Diagnostic and Reference Laboratories
    • 9.8.5. Others
  • 9.9. Market Attractiveness Analysis

10. South Asia & Oceania Multiplex Detection Immunoassay Market Outlook

  • 10.1. Key Highlights
  • 10.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 10.2.1. By Country
    • 10.2.2. By Product
    • 10.2.3. By Technique
    • 10.2.4. By Technology
    • 10.2.5. By Application
    • 10.2.6. By End User
  • 10.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 10.3.1. India
    • 10.3.2. Southeast Asia
    • 10.3.3. ANZ
    • 10.3.4. Rest of South Asia & Oceania
  • 10.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 10.4.1. Instruments
    • 10.4.2. Kits & Reagents
    • 10.4.3. Software & Services
  • 10.5. Market Size (US$ Mn) Analysis and Forecast, By Technique, 2025-2032
    • 10.5.1. Nucleic Acid Multiplex Assays
    • 10.5.2. Protein Multiplex Assays
    • 10.5.3. Cell-Based Multiplex Assays
  • 10.6. Market Size (US$ Mn) Analysis and Forecast, By Technology, 2025-2032
    • 10.6.1. Flow Cytometry
    • 10.6.2. Multiplex Bead-Based Assay
    • 10.6.3. Luminescence
    • 10.6.4. Multiplex Real-Time PCR
    • 10.6.5. Others
  • 10.7. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 10.7.1. Disease Diagnostics
    • 10.7.2. Research & Development
    • 10.7.3. Drug Discovery & Development
    • 10.7.4. Others
  • 10.8. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 10.8.1. Pharmaceutical & Biotech Companies
    • 10.8.2. Clinical Research Organizations (CROs)
    • 10.8.3. Academic Research Institutes
    • 10.8.4. Diagnostic and Reference Laboratories
    • 10.8.5. Others
  • 10.9. Market Attractiveness Analysis

11. Latin America Multiplex Detection Immunoassay Market Outlook

  • 11.1. Key Highlights
  • 11.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 11.2.1. By Country
    • 11.2.2. By Product
    • 11.2.3. By Technique
    • 11.2.4. By Technology
    • 11.2.5. By Application
    • 11.2.6. By End User
  • 11.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 11.3.1. Brazil
    • 11.3.2. Mexico
    • 11.3.3. Rest of Latin America
  • 11.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 11.4.1. Instruments
    • 11.4.2. Kits & Reagents
    • 11.4.3. Software & Services
  • 11.5. Market Size (US$ Mn) Analysis and Forecast, By Technique, 2025-2032
    • 11.5.1. Nucleic Acid Multiplex Assays
    • 11.5.2. Protein Multiplex Assays
    • 11.5.3. Cell-Based Multiplex Assays
  • 11.6. Market Size (US$ Mn) Analysis and Forecast, By Technology, 2025-2032
    • 11.6.1. Flow Cytometry
    • 11.6.2. Multiplex Bead-Based Assay
    • 11.6.3. Luminescence
    • 11.6.4. Multiplex Real-Time PCR
    • 11.6.5. Others
  • 11.7. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 11.7.1. Disease Diagnostics
    • 11.7.2. Research & Development
    • 11.7.3. Drug Discovery & Development
    • 11.7.4. Others
  • 11.8. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 11.8.1. Pharmaceutical & Biotech Companies
    • 11.8.2. Clinical Research Organizations (CROs)
    • 11.8.3. Academic Research Institutes
    • 11.8.4. Diagnostic and Reference Laboratories
    • 11.8.5. Others
  • 11.9. Market Attractiveness Analysis

12. Middle East & Africa Multiplex Detection Immunoassay Market Outlook

  • 12.1. Key Highlights
  • 12.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 12.2.1. By Country
    • 12.2.2. By Product
    • 12.2.3. By Technique
    • 12.2.4. By Technology
    • 12.2.5. By Application
    • 12.2.6. By End User
  • 12.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 12.3.1. GCC Countries
    • 12.3.2. Egypt
    • 12.3.3. South Africa
    • 12.3.4. Northern Africa
    • 12.3.5. Rest of Middle East & Africa
  • 12.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 12.4.1. Instruments
    • 12.4.2. Kits & Reagents
    • 12.4.3. Software & Services
  • 12.5. Market Size (US$ Mn) Analysis and Forecast, By Technique, 2025-2032
    • 12.5.1. Nucleic Acid Multiplex Assays
    • 12.5.2. Protein Multiplex Assays
    • 12.5.3. Cell-Based Multiplex Assays
  • 12.6. Market Size (US$ Mn) Analysis and Forecast, By Technology, 2025-2032
    • 12.6.1. Flow Cytometry
    • 12.6.2. Multiplex Bead-Based Assay
    • 12.6.3. Luminescence
    • 12.6.4. Multiplex Real-Time PCR
    • 12.6.5. Others
  • 12.7. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 12.7.1. Disease Diagnostics
    • 12.7.2. Research & Development
    • 12.7.3. Drug Discovery & Development
    • 12.7.4. Others
  • 12.8. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 12.8.1. Pharmaceutical & Biotech Companies
    • 12.8.2. Clinical Research Organizations (CROs)
    • 12.8.3. Academic Research Institutes
    • 12.8.4. Diagnostic and Reference Laboratories
    • 12.8.5. Others
  • 12.9. Market Attractiveness Analysis

13. Competition Landscape

  • 13.1. Market Share Analysis, 2025
  • 13.2. Market Structure
    • 13.2.1. Competition Intensity Mapping By Market
    • 13.2.2. Competition Dashboard
  • 13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 13.3.1. Meridian Bioscience
      • 13.3.1.1. Overview
      • 13.3.1.2. Segments and Product
      • 13.3.1.3. Key Financials
      • 13.3.1.4. Market Developments
      • 13.3.1.5. Market Strategy
    • 13.3.2. Thermo Fisher Scientific Inc.
    • 13.3.3. Bio-Rad Laboratories, Inc.
    • 13.3.4. QIAGEN
    • 13.3.5. Bio-Techne
    • 13.3.6. DiaSorin S.p.A.
    • 13.3.7. BIOMERIEUX
    • 13.3.8. Quanterix
    • 13.3.9. Randox Laboratories Ltd.
    • 13.3.10. Merck KGaA
    • 13.3.11. Revvity
    • 13.3.12. F. Hoffmann-La Roche Ltd
    • 13.3.13. Sartorius AG
    • 13.3.14. Seegene Inc.
    • 13.3.15. BioGenex
    • 13.3.16. Miltenyi Biotec
    • 13.3.17. SouthernBiotech
    • 13.3.18. Healgen
    • 13.3.19. Sepmag
    • 13.3.20. Curiox Biosystems
    • 13.3.21. MESO SCALE DIAGNOSTICS, LLC
    • 13.3.22. Wuxi NEST Biotechnology Co.,Ltd

14. Appendix

  • 14.1. Research Methodology
  • 14.2. Research Assumptions
  • 14.3. Acronyms and Abbreviations